Embracing monogenic Parkinson's disease: the MJFF global genetic PD cohort
ABSTRACT: Background: As gene-targeted therapies are increasingly being developed for Parkinson’s disease (PD), identifying and characterizing carriers of specific genetic pathogenic variants is imperative. Only a small fraction of the estimated number of subjects with monogenic…
DOI: 10.1002/mds.29288